Timothy J. Ley is a leader in science on the molecular biology of cancer. He has pioneered high throughput genome analysis in the field of leukemia and made fundamental discoveries in the molecular basis of leukemia, which are of paramount importance for our understanding of cancer development.
Dr. Ley and his team were the first to sequence the whole cancer genome in man. He discovered new recurrent cancer gene mutations and studied their clinical and biologic impact. His scientific research furnished novel and elementary insights about tumor structure, subclonal features and functional heterogeneity, in relation to the remarkable molecular diversity of human leukemia. These insights are fundamental to our understanding of cancer biology, pathogenesis and disease outcomes. Dr. Ley leads one of the major core research programs on cancer genomics in the USA and is an active participant of the Cancer Genome Atlas Research Network.
Dr. Ley is a professor of Medicine & Genetics at Washington University School of Medicine, St. Louis, Director of the Stem Cell Biology Section at the Division of Oncology, and Associate Director for Cancer Genomics at the Genome Center at Washington University, St. Louis, MO, USA.
The official ceremony and the award lecture entitled ‘The AML genome(s)’ will take place at De Doelen, Jurriaanse Kwartier, Kruisplein 30, 3012 CC Rotterdam on Thursday March 19, 2015 at 4:00-5:00 pm.
Link to official flyer of the ceremony.
Dr Ley will be the guest of the Department of Hematology at Erasmus University Medical Center.
For information please contact Prof. Dr. Pieter Sonneveld or Prof. Dr. Bob Löwenberg at 010-7033740 or Gülsüm Cam at email@example.com